In March 2019, the Coalition for Epidemic Preparedness Innovations (CEPI) announced that Nadine Gbossa joined its Board bringing her experience in inclusive growth and sustainable development to the Organization. Nadine Gbossa became one of CEPI’s 12 voting members representing competencies including industry, global health, science, resource mobilization, finance. CEPI’s Board is the primary governing body of the organization.
CEPI is a global organization based in Oslo launched in 2017 as the result of a consensus that a coordinated, international, and intergovernmental plan was needed to develop and deploy new vaccines to prevent future epidemics. Nadine Gbossa served as a CEPI Board Member from 2019 to 2022 during the COVID outbreak.
CEPI’s role was to back up a diverse range of vaccine candidates to increase the chances of developing multiple successful vaccines, which is crucial to meet global demand and protect vulnerable populations.
As a CEPI Board member, Nadine Gbossa provided vision, direction and leadership to ensure the organization harnesses global goodwill, stays close to its founding principles, and holds itself accountable to its mission in accordance with its Board Charter and articles of association. Under the leadership of its Board, CEPI partnered with WHO and Gavi to launch COVAX to accelerate the development and manufacture of COVID-19 vaccines, and to deliver fair and equitable access for every country in the world. COVAX provides countries access to CEPI’s portfolio of COVID-19 vaccine candidates – the largest in the world. The breadth of CEPI’s portfolio increased the chances of developing multiple successful vaccines.
CEPI brings in an innovative global partnership public, private, philanthropic, and civil society organisations. They work together to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to these vaccines for people during outbreaks.
Visit CEPI at: https://cepi.net/
Comments